CAS OpenIR  > 中科院上海原子核所2003年前
俎建华; 吴元芳; 董墨; 李惠源; 张雨龙; 兰青
Source Publication同位素
Abstract本工作对单克隆抗体 MAb- SZ39的铼标记物进行动物体内稳定性、免疫活性、细胞杀伤能力及对荷人脑胶质瘤裸鼠的抑制率等测试。结果表明标记物细胞杀伤能力强 ;体内较稳定 ;且能明显抑制肿瘤的生长 ;作为一种免疫治疗剂具有良好的应用前景。
Indexed ByCNKI
Funding Project原子核所项目组
Document Type期刊论文
Recommended Citation
GB/T 7714
俎建华,吴元芳,董墨,等. ~(186;188)Re-SZ39的药学性能研究[J]. 同位素,2000(03).
APA 俎建华,吴元芳,董墨,李惠源,张雨龙,&兰青.(2000).~(186;188)Re-SZ39的药学性能研究.同位素(03).
MLA 俎建华,et al."~(186;188)Re-SZ39的药学性能研究".同位素 .03(2000).
Files in This Item:
File Name/Size DocType Version Access License
~(186;188)Re-SZ39的药学(82KB) 开放获取LicenseView Application Full Text
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[俎建华]'s Articles
[吴元芳]'s Articles
[董墨]'s Articles
Baidu academic
Similar articles in Baidu academic
[俎建华]'s Articles
[吴元芳]'s Articles
[董墨]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[俎建华]'s Articles
[吴元芳]'s Articles
[董墨]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: ~(186;188)Re-SZ39的药学性能研究.caj
Format: Unknown
This file does not support browsing at this time
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.